(FTGN) First Trust Vest U.S. - Ratings and Ratios
Buffered, Equity, Options, Risk, Management
Description: FTGN First Trust Vest U.S.
The First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November Class A USD Acc EUR is an exchange-traded fund listed on XETRA, providing investors with exposure to U.S. equities while incorporating a moderate buffer strategy to mitigate potential losses.
This ETF is designed to track the performance of the U.S. equity market with a buffer against potential downturns, making it an attractive option for investors seeking to balance risk and potential returns. The fund achieves this through the use of options trading strategies, which are employed to provide a level of protection against losses.
Analyzing the ETFs recent performance, we observe that it has been trending upwards, as indicated by its current price of 27.86 being above both its 20-day and 50-day simple moving averages (SMA20: 26.95, SMA50: 27.25). However, it remains below its 200-day simple moving average (SMA200: 28.44), suggesting a potential resistance level. The Average True Range (ATR) of 0.50, or 1.79%, indicates moderate volatility, which is expected given the funds exposure to U.S. equities and its use of options.
Considering the Assets Under Management (AUM) of 47.38M EUR, the ETF has a relatively modest size, which may impact its liquidity and trading costs. However, its listing on XETRA provides a level of accessibility and transparency for investors.
Based on the technical and fundamental data, a forecast for the ETF could be constructed. Given the current trends and indicators, a potential short-term target could be the 52W High of 30.66, assuming the upward trend continues and volatility remains moderate. Conversely, a decline below the 52W Low of 25.57 could signal a more significant downturn. Therefore, investors may consider a cautious approach, monitoring the ETFs price action relative to its moving averages and adjusting their strategies accordingly.
To further refine this forecast, it would be essential to monitor the underlying U.S. equity markets performance, as well as any changes in the ETFs holdings and options strategies. A more detailed analysis of the ETFs options trading strategies and their impact on its performance could provide additional insights into its potential future trajectory.
Additional Sources for FTGN ETF
FTGN ETF Overview
Market Cap in USD | 56m |
Category | Options Trading |
IPO / Inception | 2023-11-17 |
FTGN ETF Ratings
Growth Rating | 20.9 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -23.1 |
Analysts | - |
Fair Price Momentum | 24.91 EUR |
Fair Price DCF | - |
FTGN Dividends
Currently no dividends paidFTGN Growth Ratios
Growth Correlation 3m | 45.2% |
Growth Correlation 12m | -3.2% |
Growth Correlation 5y | 52.1% |
CAGR 5y | 5.66% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 0.39 |
Alpha | -7.54 |
Beta | 0.355 |
Volatility | 6.95% |
Current Volume | 2.6k |
Average Volume 20d | 0.2k |
Stop Loss | 26.7 (-3.5%) |
As of July 13, 2025, the stock is trading at EUR 27.68 with a total of 2,599 shares traded.
Over the past week, the price has changed by +0.97%, over one month by +0.18%, over three months by +7.71% and over the past year by +0.13%.
Neither. Based on ValueRay´s Analyses, First Trust Vest U.S. is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.86 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FTGN is around 24.91 EUR . This means that FTGN is currently overvalued and has a potential downside of -10.01%.
First Trust Vest U.S. has no consensus analysts rating.
According to our own proprietary Forecast Model, FTGN First Trust Vest U.S. will be worth about 27.6 in July 2026. The stock is currently trading at 27.68. This means that the stock has a potential downside of -0.33%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 27.6 | -0.3% |